Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.sncl.com | |
Market Cap | 2,347.42 Cr. | |
Enterprise Value(EV) | 2,450.04 Cr. | 2021-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.87 | Trailing Twelve Months Ending 2021-12 |
Price-Earning Ratio (PE) | 137.92 | Trailing Twelve Months Ending 2021-12 |
Industry PE | 31.20 | Trailing Twelve Months Ending 2021-12 |
Book Value / Share | 6.92 | Trailing Twelve Months Ending 2021-12 |
Price to Book Value | 17.33 | Calculated using Price: 120.00 |
Dividend Yield | 0.00 | Period Ending 2021-03 |
No. of Shares Subscribed | 19.56 Cr. | 195,618,129 Shares |
FaceValue | 1 | |
Company Profile | ||
In 1973 a small beginning was made in the field of chemicals with the establishment of Sadhana Nitro Chem (SNCL) - a company that was committed to producing high quality chemical intermediates by setting up with 12,000 TPA plant in Roha, 135 Kms. from its Head Office in the metropolis of Mumbai, SNCL, an existing listed, public limited company was promoted by its founder Chairman D.T.Javeri with other co-promoters for the manufacture of 9000 TPA of Nitrobenzene based on the technology from AB Chematur Division of the Nobel Industries, Sweden. At present, SNCL is engaged in the manufacture and marketing of Nitrobenzene (12000 TPA) and its downstream derivatives and intermediates (4000 TPA) for various applications in Pharma, Agro, Dyes, Plastic Additives & Epoxy resin hardeners. In 1979 the company diversified into the manufacture of downstream products viz., Metanilic Acid and Sodium Meta Nitrobenzene sulphonate. Based on the in-house technology. SNCL has also set up projects for manufacture of 3,3 Dinitro Diphenyl Sulphone, Aniline 2,5 Disulphonic acid, Aniline 2,4 Disulphonic acid. In 1995 SNCL commissioned a 550 TPA plant to manufacture Meta Amino Phenol. This project was set up in technical collaboration with Biazzi S.A., Switzerland. As a reputed manufacturer SNCL has been able to enter into contracts with foreign companies for custom and toll manufacturing. In the year 2000 a new 350 TPA plant to produce Butane Tetra 1,2,3,4 Carboxylic Acid was commissioned. In its R & D Laboratory, there is development work is going on for new chemical intermediates. Since inception, SNCL has devoted its resources exclusively for manufacture and sale of intermediates. Production of intermediates under rigid quality standards has been the hallmark of SNCL's success in attuning and propelling it to customer requirements. The transition of product line, with reliance on its well-equipped quality control laboratory has been the motivating force in sustaining growth and export, in competition with giants in the international market, satisfying highly discerning and quality conscious clients, including multinationals, spread across the world. In recognition of its superior performance, SNCL has been granted the status of a 'Golden Export House' by the Directorate General of Foreign Trade, Ministry of Commerce, and Government of India. Now SNCL has step up in the area of Information Technology, starting its new division as ‘Sadhana Webworks’, which is providing Total IT Solutions for our clients around the world. Subsidiary:SNCL also has a 100% subsidiary Anuchem b.v.b.a. Antwerp, Belgium set up to provide ‘Just in Time Service’ to its clientele in Europe. Product range of the company includes:
Achievements/ recognition:
|
1 Day |
|
+4.99% |
1 Week |
|
+1.87% |
1 Month |
|
-5.66% |
3 Month |
|
-8.50% |
6 Month |
|
+183.35% |
1 Year |
|
+277.48% |
2 Year |
|
+847.87% |
5 Year |
|
+4052.25% |
10 Year |
|
+16801.41% |
9 years | 2013-06 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | |
Return on Equity (%) | 752.77 | 12.68 | 110.55 | 101.05 | 13.28 | 12.94 | ||||
Return on Capital Employed (%) | 28.47 | 16.15 | 20.50 | 0.38 | 15.89 | 64.42 | 135.94 | 18.57 | 11.76 | |
Return on Assets (%) | 5.45 | -1.01 | 6.21 | -7.39 | 0.67 | 28.41 | 48.47 | 7.47 | 6.53 |
Particulars | 10 years | 2013-06 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2021-09* Rs. Cr. |
Shh. Funds | 1 | 0 | 12 | 7 | 10 | 46 | 105 | 116 | 130 | 134 | |
Non Curr. Liab. | 5 | 3 | 2 | 2 | 20 | 6 | 7 | 14 | 37 | 48 | |
Curr. Liab. | 65 | 58 | 52 | 59 | 52 | 84 | 64 | 86 | 105 | 121 | |
Minority Int. | |||||||||||
Equity & Liab. | 72 | 62 | 66 | 68 | 83 | 136 | 177 | 216 | 272 | 302 | |
Non Curr. Assets | 39 | 37 | 41 | 39 | 49 | 77 | 81 | 104 | 122 | 136 | |
Curr. Assets | 32 | 25 | 24 | 29 | 34 | 59 | 96 | 112 | 151 | 167 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 72 | 62 | 66 | 68 | 83 | 136 | 177 | 216 | 272 | 302 |
Particulars | 10 years | 2013-06 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2021-12 Rs. Cr. TTM |
Net Sales | 72 | 32 | 48 | 36 | 55 | 114 | 267 | 106 | 103 | 131 | |
Other Income | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 2 | 5 | 2 | |
Total Income | 72 | 33 | 49 | 36 | 56 | 114 | 268 | 108 | 108 | 133 | |
Total Expenditure | -66 | -34 | -52 | -34 | -47 | -78 | -147 | -77 | -80 | -102 | |
PBIDT | 7 | -1 | -3 | 2 | 9 | 37 | 122 | 31 | 28 | 31 | |
Interest | -10 | -6 | -5 | -5 | -6 | -7 | -12 | -3 | -3 | -4 | |
Depreciation | -4 | -2 | -2 | -2 | -2 | -2 | -3 | -6 | -6 | -6 | |
Taxation | -2 | -2 | 1 | 3 | -31 | -8 | -3 | -3 | |||
Exceptional Items | 14 | 11 | 13 | ||||||||
PAT | 4 | -1 | 4 | -5 | 1 | 31 | 76 | 15 | 16 | 17 | |
Minority Interest | |||||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 4 | -1 | 4 | -5 | 1 | 31 | 76 | 15 | 16 | 17 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 2 | 4 | 1 | 1 | 1 |
Particulars | 10 years | 2012-03 Rs. Cr. | 2013-06 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
Cash Fr. Operatn. | 8 | 6 | 6 | 9 | -1 | 9 | 35 | 53 | -17 | 1 | |
Cash Fr. Inv. | -2 | -2 | 11 | 0 | 0 | -1 | -6 | -25 | -22 | -23 | |
Cash Fr. Finan. | -6 | -4 | -18 | -9 | 2 | -25 | -13 | -23 | 30 | 30 | |
Net Change | 0 | 0 | -1 | 0 | 1 | -17 | 16 | 5 | -9 | 7 | |
Cash & Cash Eqvt | 1 | 1 | 0 | 0 | 1 | -15 | 0 | 5 | -4 | 4 |
Wed, 18 May 2022
Update on board meeting SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2022 inter alia to consider and approve In continuation of our intimation dated May 17 2022 we herebywish to inform you that the meeting of the Board of Directors of Sadhana Nitro Chem Limited (the Company) is scheduled to be held on Tuesday May 24 2022 in addition and inter alia to also consider and approve the following transaction:1. Recommendation of Dividend if any for the Financial Year 2021-22. |
Wed, 18 May 2022
Corporate Action-Board to consider Dividend In continuation of our intimation dated May 17 2022 we hereby wish to inform you that the meeting of the Board of Directors of Sadhana Nitro Chem Limited (the Company) is scheduled to be held on Tuesday May 24 2022 in addition and inter alia to also consider and approve the following transaction:1. Recommendation of Dividend if any for the Financial Year 2021-22. |
Tue, 17 May 2022
Board Meeting Intimation for Intimation Of The Board Meeting SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 it is hereby informed that the meeting of the Board of Directors of Sadhana Nitro Chem Limited (the Company) is scheduled to be held on Tuesday May 24 2022 inter-alia to consider and approve the following transactions:1. Audited Standalone and Consolidated Financial Results and Statements for the quarter and Financial Year ended March 31 2022.2. Any other business that may arise out of the discussion of the Board |
Wed, 18 May 2022 |
|
|
|
|
|